Document is current
Any future updates will be listed below
-
Authors
Bakhtiar, Hamza
Sharifi, Marina N. https://orcid.org/0000-0003-0128-3033
Helzer, Kyle T.
Shi, Yue
Bootsma, Matthew L.
Shang, Tianfu A.
Chrostek, Matthew R. https://orcid.org/0000-0002-9457-1431
Berg, Tracy J.
Carson Callahan, S. https://orcid.org/0000-0002-0152-2666
Carreno, Viridiana
Blitzer, Grace C.
West, Malinda T.
O’Regan, Ruth M.
Wisinski, Kari B.
Sjöström, Martin https://orcid.org/0000-0002-2629-9966
Zhao, Shuang G. https://orcid.org/0000-0002-9166-6507
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2-OD030734, P30-CA014520)
U.S. Department of Health & Human Services | National Institutes of Health
Doris Duke Charitable Foundation (PSF-2021088)
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 22 September 2024
First Online: 2 October 2024
Competing interests
: K.T.H. has a family member who is an employee of Epic Systems. M.L.B. has a family member who is an employee of Luminex. S.G.Z. reports unrelated patents licensed to Veracyte, and that a family member is an employee of Artera and holds stock in Exact Sciences. M.N.S reports research support from Novartis unrelated to the current study. H.B., S.G.Z., and the University of Wisconsin have filed a patent on phenocopy signatures in cancer (USSN 18/326364; 18/522977).
